NCT00697073View on ClinicalTrials.gov

Study to Assess the Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Friedreich's Ataxia
Interventions
DRUG

Idebenone

Patients ≤ 45 kg/99 lbs: idebenone 1350 mg/day; Patients \> 45 kg/99 lbs: idebenone 2250 mg/day

Trial Locations (2)

19104

The Children's Hopsital of Philadelphia, Philadelphia

90095-1769

David Geffen School of Medicine, UCLA, Los Angeles

Sponsors
All Listed Sponsors
lead

Santhera Pharmaceuticals

INDUSTRY